Yuexia Liang

759 total citations
15 papers, 367 citations indexed

About

Yuexia Liang is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Yuexia Liang has authored 15 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Yuexia Liang's work include Drug Transport and Resistance Mechanisms (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Yuexia Liang is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Yuexia Liang collaborates with scholars based in United States, China and Switzerland. Yuexia Liang's co-authors include Limin Guo, Haijing Zhang, Robert E. Serfass, Wendy S. White, Lihang Yao, Wensheng Zhang, Ping Su, Walter S. Trahanovsky, Rosa I. Sánchez and Xiaoyan Chu and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and European Journal of Pharmacology.

In The Last Decade

Yuexia Liang

14 papers receiving 362 citations

Peers

Yuexia Liang
Youmei Peng China
Shentian Zhuang China
Miriam Durante Italy
Mao‐Feng Sun Taiwan
Sanjana Haque United States
Su‐Sen Chang Taiwan
William G. Stirtan United States
Rackhyun Park South Korea
Anna Furimsky United States
Derek J. Leishman United States
Youmei Peng China
Yuexia Liang
Citations per year, relative to Yuexia Liang Yuexia Liang (= 1×) peers Youmei Peng

Countries citing papers authored by Yuexia Liang

Since Specialization
Citations

This map shows the geographic impact of Yuexia Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuexia Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuexia Liang more than expected).

Fields of papers citing papers by Yuexia Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuexia Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuexia Liang. The network helps show where Yuexia Liang may publish in the future.

Co-authorship network of co-authors of Yuexia Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuexia Liang. A scholar is included among the top collaborators of Yuexia Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuexia Liang. Yuexia Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Menzel, Karsten, et al.. (2025). An Intravenous Study with the Radiolabeled sGC Stimulator Frespaciguat to Assess PK, Metabolism, and Mass Balance. The Journal of Clinical Pharmacology. 65(11). 1561–1567.
2.
Li, Wenkui, Gordon J. Dear, Jason Boer, et al.. (2023). Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group. Clinical Pharmacology & Therapeutics. 115(5). 939–953. 1 indexed citations
3.
Liang, Yuexia, Xin Li, Fengping Peng, et al.. (2022). Self-assembly of X-shaped antibody to combine the activity of IgG and IgA for enhanced tumor killing. Theranostics. 12(18). 7729–7744. 4 indexed citations
4.
Lutz, Ryan, et al.. (2019). Carboxylesterase catalyzed 18O-labeling of carboxylic acid and its potential application in LC-MS/MS based quantification of drug metabolites. Drug Metabolism and Pharmacokinetics. 34(5). 308–316. 8 indexed citations
5.
Sánchez, Rosa I., Kerry L. Fillgrove, Ka Lai Yee, et al.. (2018). Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans. Xenobiotica. 49(4). 422–432. 43 indexed citations
6.
Zhang, Haijing, Chunhui Zhao, Limin Guo, et al.. (2017). Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase. Neuropharmacology. 125. 408–417. 44 indexed citations
7.
Su, Ping, et al.. (2016). Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells. European Journal of Pharmacology. 793. 101–108. 78 indexed citations
8.
Chu, Xiaoyan, Xiaoxin Cai, Donghui Cui, et al.. (2013). In Vitro Assessment of Drug-Drug Interaction Potential of Boceprevir Associated with Drug Metabolizing Enzymes and Transporters. Drug Metabolism and Disposition. 41(3). 668–681. 48 indexed citations
9.
Gomez, Robert, Samson M. Jolly, Theresa M. Williams, et al.. (2011). Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 21(24). 7344–7350. 22 indexed citations
10.
Gomez, Robert, Theresa M. Williams, Joseph P. Vacca, et al.. (2011). Design and Synthesis of Conformationally Constrained Inhibitors of Non-Nucleoside Reverse Transcriptase. Journal of Medicinal Chemistry. 54(22). 7920–7933. 32 indexed citations
11.
Chu, Xiaoyan, Yuexia Liang, Xiaoxin Cai, et al.. (2008). Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters. Pharmaceutical Research. 26(2). 459–468. 16 indexed citations
12.
Liang, Yuexia, et al.. (2006). Quantitation of geometric isomers of a phosphodiesterase inhibitor in rat and monkey plasma using liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 41(4). 1293–1298. 1 indexed citations
13.
Shou, Magang, Wei Lü, Prasad H. Kari, et al.. (2005). Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey. European Journal of Pharmaceutical Sciences. 26(2). 151–161. 21 indexed citations
14.
Yao, Lihang, Yuexia Liang, Walter S. Trahanovsky, Robert E. Serfass, & Wendy S. White. (2000). Use of a 13C tracer to quantify the plasma appearance of a physiological dose of lutein in humans. Lipids. 35(3). 339–348. 34 indexed citations
15.
Liang, Yuexia, Wendy S. White, Lihang Yao, & Robert E. Serfass. (1998). Use of high-precision gas isotope ratio mass spectrometry to determine natural abundance 13C in lutein isolated from C3 and C4 plant sources. Journal of Chromatography A. 800(1). 51–58. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youmei Peng Breakdown of academic impact, for papers by Shentian Zhuang Breakdown of academic impact, for papers by Miriam Durante Breakdown of academic impact, for papers by Mao‐Feng Sun Breakdown of academic impact, for papers by Sanjana Haque Breakdown of academic impact, for papers by Su‐Sen Chang Breakdown of academic impact, for papers by William G. Stirtan Breakdown of academic impact, for papers by Rackhyun Park Breakdown of academic impact, for papers by Anna Furimsky Breakdown of academic impact, for papers by Derek J. Leishman
Rankless by CCL
2026